Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Beijing Municipal Science & Technology Commission | OTHER |
Not provided
Not provided
Not provided
Not provided
Coronary artery bypass grafting(CABG) is the golden standard for severe coronary artery disease(CAD), the current surgery strategy is mainly based on coronary angiography(CAG), but many trials of PCI have shown that visually stenosis in CAG may not have functional significance. The aim of this study is to investigate if the Quantitative Flow Ratio (QFR) can be adopted in CABG and achieve a better graft patency.
CABG is the major treatment of three vessels or left main disease. CAG is the main basis on choosing the vessels to graft, however, some of the grafts occluded shortly after surgery due to competitive flow, these vessels may not be significantly stenosis in functional assessment such as Fractional Flow Reserve (FFR). Quantitative Flow Ratio (QFR) is a novel method for evaluating the functional significance of coronary stenosis. Comparing to FFR, there is no need for pressure wire or ATP when performing QFR. This study plan to investigate the clinical effect of QFR in CABG, all patients included will be allocated 1:1 into two groups: QFR-guided and Angio-guided, QFR-guided group will be performed a CABG based on the result of QFR, the other group will be based on heart team discussion of CAG, CTA will be adopted to evaluate the 1 year graft patency.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| QFR-guided | Experimental | This group will be performed a CABG surgery based on CAG and QFR, whether graft the moderate stenosis vessels will be based on the result of QFR. |
|
| Angio-guided | Active Comparator | This group will be performed a CABG surgery only based on CAG, the final surgery strategy will be decided after the discussion of heart team. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| QFR-guided CABG | Procedure | CABG surgery based on CAG and QFR |
| |
| Measure | Description | Time Frame |
|---|---|---|
| The rate of graft patency | graft patency will be evaluated by CTA, 2 doctors will be invited to read the CT and draw their own conclusion without knowing the other result | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Major adverse cardiovascular event(MACE) | The rate of deaths due to cardiovascular events, myocardial infarction and second revascularization | 12 months |
| The rate of angina relief | whether angina is relieved will be evaluated |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Yang Zhao, MD | Contact | 13810050821 | allen_hya731@sohu.com |
| Name | Affiliation | Role |
|---|---|---|
| Ran Dong, MD | Beijing Anzhen Hospital | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Beijing Anzhen Hospital | Recruiting | Beijing | Beijing Municipality | 100029 | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003324 | Coronary Artery Disease |
| D017202 | Myocardial Ischemia |
| ID | Term |
|---|---|
| D003327 | Coronary Disease |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D001161 | Arteriosclerosis |
Not provided
Not provided
Not provided
Not provided
Not provided
QFR will be masked to care providers and participants, and open to investigators, the allocation will be based on QFR.
| Angio-guided CABG |
| Procedure |
CABG surgery based on heart team discussion of CAG |
|
| 12 months |
| D001157 |
| Arterial Occlusive Diseases |
| D014652 | Vascular Diseases |